The present invention relates to certain DPP-4 inhibitors for treating and/orpreventing oxidative stress, vascular stress and/or endothelial dysfunction aswell asto the use of such DPP-4 inhibitors in treatment and/or prevention of diabeticornon-diabetic patients, including patient groups at risk of cardiovascularand/or renaldisease.